A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
Misleading Reporting in Statistically Not Significant Oncology Trials-Joining Efforts Toward Unbiased Results Interpretation
2021
Over the past decades, randomized clinical trials (RCTs) have gradually been accepted as the criterion standard to test the efficacy and safety of new treatments. Results from RCTs are widely used to inform regulatory approvals and clinical practices. To enable assessments of the validity of their results and conclusions, an RCT report should provide comprehensive information on its design, conduct, and analysis objectively. Previous approaches to reporting RCT results revealed many
doi:10.1001/jamanetworkopen.2021.38695
pmid:34874408
fatcat:j3nkqhotdbc4zc7x43fjbso6km